189 related articles for article (PubMed ID: 36905391)
1. Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study.
Gao Y; Liu CJ; Li HY; Xiong XM; Li GL; In 't Veld SGJG; Cai GY; Xie GY; Zeng SQ; Wu Y; Chi JH; Liu JH; Zhang Q; Jiao XF; Shi LL; Lu WR; Lv WG; Yang XS; Piek JMJ; de Kroon CD; Lok CAR; Supernat A; Łapińska-Szumczyk S; Łojkowska A; Żaczek AJ; Jassem J; Tannous BA; Sol N; Post E; Best MG; Kong BH; Xie X; Ma D; Wurdinger T; Guo AY; Gao QL
Protein Cell; 2023 Jun; 14(6):579-590. PubMed ID: 36905391
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of core genes in tumor-educated platelets for human gastrointestinal tumor diagnosis using network-based transcriptomic analysis.
Jiang Y; He J; Wang X; Liu C; Zhou W; Liu D; Guo Z; Liu K
Platelets; 2023 Dec; 34(1):2212071. PubMed ID: 37212262
[TBL] [Abstract][Full Text] [Related]
3. The role of tumor-educated platelets in ovarian cancer: A comprehensive review and update.
Patel D; Thankachan S; Sreeram S; Kavitha KP; Suresh PS
Pathol Res Pract; 2023 Jan; 241():154267. PubMed ID: 36509009
[TBL] [Abstract][Full Text] [Related]
4. Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors.
Huang K; Xu S; Wang J; Ge L; Xu J; Jia X
J Ovarian Res; 2023 Feb; 16(1):37. PubMed ID: 36759870
[TBL] [Abstract][Full Text] [Related]
5. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Educated Platelets as a Promising Biomarker for Blood-Based Detection of Renal Cell Carcinoma.
Xiao R; Liu C; Zhang B; Ma L
Front Oncol; 2022; 12():844520. PubMed ID: 35321426
[TBL] [Abstract][Full Text] [Related]
7. TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction.
Li X; Liu L; Song X; Wang K; Niu L; Xie L; Song X
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1609-1622. PubMed ID: 33792796
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing platelet isolation: a prospective multicenter study from Western China.
Liu S; Yang G; Zeng G; Zhou X; Chen R; Chen B; Chen J; Wen X; Zhang X; Ren H; Zu R; Wang D; Leng P; Luo H
Platelets; 2023 Dec; 34(1):2194445. PubMed ID: 37041749
[TBL] [Abstract][Full Text] [Related]
9. Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China.
He P; Wang JJ; Duan W; Song C; Yang Y; Wu QQ
J Ovarian Res; 2021 Dec; 14(1):169. PubMed ID: 34857005
[TBL] [Abstract][Full Text] [Related]
10. OCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study.
Kandimalla R; Wang W; Yu F; Zhou N; Gao F; Spillman M; Moukova L; Slaby O; Salhia B; Zhou S; Wang X; Goel A
Clin Cancer Res; 2021 Aug; 27(15):4277-4286. PubMed ID: 34035068
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma.
Sol N; In 't Veld SGJG; Vancura A; Tjerkstra M; Leurs C; Rustenburg F; Schellen P; Verschueren H; Post E; Zwaan K; Ramaker J; Wedekind LE; Tannous J; Ylstra B; Killestein J; Mateen F; Idema S; de Witt Hamer PC; Navis AC; Leenders WPJ; Hoeben A; Moraal B; Noske DP; Vandertop WP; Nilsson RJA; Tannous BA; Wesseling P; Reijneveld JC; Best MG; Wurdinger T
Cell Rep Med; 2020 Oct; 1(7):100101. PubMed ID: 33103128
[TBL] [Abstract][Full Text] [Related]
12. Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study.
Wu J; Yin H; Zhu J; Buckanovich RJ; Thorpe JD; Dai J; Urban N; Lubman DM
PLoS One; 2015; 10(3):e0121112. PubMed ID: 25799488
[TBL] [Abstract][Full Text] [Related]
13. Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.
Best MG; Sol N; In 't Veld SGJG; Vancura A; Muller M; Niemeijer AN; Fejes AV; Tjon Kon Fat LA; Huis In 't Veld AE; Leurs C; Le Large TY; Meijer LL; Kooi IE; Rustenburg F; Schellen P; Verschueren H; Post E; Wedekind LE; Bracht J; Esenkbrink M; Wils L; Favaro F; Schoonhoven JD; Tannous J; Meijers-Heijboer H; Kazemier G; Giovannetti E; Reijneveld JC; Idema S; Killestein J; Heger M; de Jager SC; Urbanus RT; Hoefer IE; Pasterkamp G; Mannhalter C; Gomez-Arroyo J; Bogaard HJ; Noske DP; Vandertop WP; van den Broek D; Ylstra B; Nilsson RJA; Wesseling P; Karachaliou N; Rosell R; Lee-Lewandrowski E; Lewandrowski KB; Tannous BA; de Langen AJ; Smit EF; van den Heuvel MM; Wurdinger T
Cancer Cell; 2017 Aug; 32(2):238-252.e9. PubMed ID: 28810146
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women.
Nikolova T; Zivadinovic R; Evtimovska N; Klisarovska V; Stanojevic M; Georgievska J; Nikolova N
J Obstet Gynaecol Res; 2017 Dec; 43(12):1870-1879. PubMed ID: 29027715
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.
Arakawa N; Kobayashi H; Yonemoto N; Masuishi Y; Ino Y; Shigetomi H; Furukawa N; Ohtake N; Miyagi Y; Hirahara F; Hirano H; Miyagi E
PLoS One; 2016; 11(10):e0165609. PubMed ID: 27798689
[TBL] [Abstract][Full Text] [Related]
16. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.
Lenhard M; Stieber P; Hertlein L; Kirschenhofer A; Fürst S; Mayr D; Nagel D; Hofmann K; Krocker K; Burges A
Clin Chem Lab Med; 2011 Sep; 49(12):2081-8. PubMed ID: 21923475
[TBL] [Abstract][Full Text] [Related]
18. Comparison of plasma amino acid profile-based index and CA125 in the diagnosis of epithelial ovarian cancers and borderline malignant tumors.
Miyagi E; Maruyama Y; Mogami T; Numazaki R; Ikeda A; Yamamoto H; Hirahara F
Int J Clin Oncol; 2017 Feb; 22(1):118-125. PubMed ID: 27623814
[TBL] [Abstract][Full Text] [Related]
19. HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients.
Braicu EI; Krause CL; Torsten U; Mecke H; Richter R; Hellmeyer L; Lanowska M; Müller B; Koch E; Boenneß-Zaloum J; Ames K; Chekerov R; Hasenbein K; Zimmermann M; Mangler M; Chen F; Tauber R; Sehouli J
BMC Cancer; 2022 Jul; 22(1):831. PubMed ID: 35907794
[TBL] [Abstract][Full Text] [Related]
20. Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer.
Gu Z; He Y; Zhang Y; Chen M; Song K; Huang Y; Li Q; Di W
J Transl Med; 2018 May; 16(1):114. PubMed ID: 29716620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
